Based on the Scholar Rock Holding Corp stock forecast from 7 analysts, the average analyst target price for Scholar Rock Holding Corp is USD 37.60 over the next 12 months. Scholar Rock Holding Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Scholar Rock Holding Corp is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Scholar Rock Holding Corp’s stock price was USD 37.06. Scholar Rock Holding Corp’s stock price has changed by +33.02% over the past week, +23.91% over the past month and +209.61% over the last year.
No recent analyst target price found for Scholar Rock Holding Corp
No recent average analyst rating found for Scholar Rock Holding Corp
Company Overview Scholar Rock Holding Corp
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts. Read Less
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibi...Read More
Frequently Asked Questions About Scholar Rock Holding Corp (SRRK) Stock
Based on ratings from 7 analysts Scholar Rock Holding Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 10 buy, sell and hold ratings.
Unfortunately we do not have enough data on SRRK's stock to indicate if its a good dividend stock.
Based on targets from 7 analysts, the average taret price for SRRK is USD 37.60 over the next 12 months. The maximum analyst target price is USD 50 while the minimum anlayst target price is USD 18.
Unfortunately we do not have enough data on SRRK's stock to indicate if its overvalued.
The last closing price of SRRK's stock was USD 37.06.
The most recent market capitalization for SRRK is USD 2.68B.
Based on targets from 7 analysts, the average taret price for SRRK is projected at USD 37.60 over the next 12 months.
This means that SRRK's stock price may go up by +1.46% over the next 12 months.
We can't find any ETFs which contains Scholar Rock Holding Corp's stock.
As per our most recent records Scholar Rock Holding Corp has 150 Employees.
Scholar Rock Holding Corp's registered address is 301 Binney Street, Cambridge, MA, United States, 02142.
You can get more information about it from Scholar Rock Holding Corp's website at https://scholarrock.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Scholar Rock Holding Corp (SRRK) Stock
Based on ratings from 7 analysts Scholar Rock Holding Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 10 buy, sell and hold ratings.
Unfortunately we do not have enough data on SRRK's stock to indicate if its a good dividend stock.
Based on targets from 7 analysts, the average taret price for SRRK is USD 37.60 over the next 12 months. The maximum analyst target price is USD 50 while the minimum anlayst target price is USD 18.
Unfortunately we do not have enough data on SRRK's stock to indicate if its overvalued.
The last closing price of SRRK's stock was USD 37.06.
The most recent market capitalization for SRRK is USD 2.68B.
Based on targets from 7 analysts, the average taret price for SRRK is projected at USD 37.60 over the next 12 months.
This means that SRRK's stock price may go up by +1.46% over the next 12 months.
We can't find any ETFs which contains Scholar Rock Holding Corp's stock.
As per our most recent records Scholar Rock Holding Corp has 150 Employees.
Scholar Rock Holding Corp's registered address is 301 Binney Street, Cambridge, MA, United States, 02142.
You can get more information about it from Scholar Rock Holding Corp's website at https://scholarrock.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SRRK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
